Lv2
130 积分 2024-01-24 加入
Inflammation and tumor immune escape in response to DNA damage
6小时前
待确认
Association of proteinuria with improved prognosis in unresectable hepatocellular carcinoma treated with atezolizumab and bevacizumab, and the predictive role of serum vascular endothelial growth factor D levels: A multicenter retrospective study
17天前
已完结
RECIST 1.1—Update and clarification: From the RECIST committee
1个月前
已完结
Spatial immune scoring system predicts hepatocellular carcinoma recurrence
2个月前
已完结
Roles of intestinal microbiota in response to cancer immunotherapy
4个月前
已完结
Update on novel validly published and included bacterial taxa derived from human clinical specimens and taxonomic revisions published in 2023
4个月前
已完结
Gut Bacteria Composition Drives Primary Resistance to Cancer Immunotherapy in Renal Cell Carcinoma Patients
4个月前
已完结
The Current Landscape of Immune Checkpoint Blockade in Hepatocellular Carcinoma
4个月前
已完结
The Role of Immune Checkpoint Blockade in the Hepatocellular Carcinoma: A Review of Clinical Trials
4个月前
已完结
Nivolumab versus sorafenib in advanced hepatocellular carcinoma (CheckMate 459): a randomised, multicentre, open-label, phase 3 trial
4个月前
已完结
皖公网安备34019202002308
